The fas locus of the phytopathogen Rhodococcus fascians affects mitosis of tobacco BY-2 cells  by Temmerman, Wim et al.
The fas locus of the phytopathogen Rhodococcus fascians a¡ects mitosis
of tobacco BY-2 cells
Wim Temmerman, Tita Ritsema1, Carmen Simo¤n-Mateo2, Marc Van Montagu,
Vladimir Mironov3, Dirk Inze¤, Koen Goethals, Marcelle Holsters*
Vakgroep Moleculaire Genetica and Departement Plantengenetica, Vlaams Interuniversitair Instituut voor Biotechnologie (VIB), Universiteit Gent,
K.L. Ledeganckstraat 35, B-9000 Gent, Belgium
Received 15 December 2000; revised 9 February 2001; accepted 12 February 2001
First published online 23 February 2001
Edited by Ulf-Ingo Flu«gge
Abstract The effect of Rhodococcus fascians, the causal agent
of leafy gall disease, on the mitotic behavior of synchronized
tobacco Bright Yellow-2 (BY-2) cells was investigated. Incuba-
tion of aphidicolin-synchronized BY-2 cells with R. fascians cells
specifically resulted in a broader mitotic index peak, an effect
that was linked to an intact and expressed fas virulence locus.
The obtained results pointed towards an effect of R. fascians on
the prophase of mitosis. The relevance of these results to the
virulence of the bacterium is discussed. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
The Gram-positive phytopathogen Rhodococcus fascians in-
teracts with many plant species, provoking a variety of symp-
toms related to a massive production of shoot primordia [1,2].
Disease development depends on several virulence loci that
reside on a large linear plasmid, called pFiD188 [3,4]. The
fas1 mutant, carrying an insertion into the gene encoding
isopentenyl transferase (ipt) is completely non-virulent [3], in-
dicating the essential role of the fas locus in pathogenesis.
Several observations suggest that a R. fascians elicited e¡ect
on the plant cell cycle. In all eukaryotes, the cell cycle is
controlled at speci¢c transition checkpoints. The key catalytic
enzymes exerting this control are the cyclin-dependent kinases
(CDKs), the activity of which is subjected to a complex reg-
ulation (for reviews, see [5,6]). Meristematic tissues are sensi-
tive to the action of R. fascians [7^10] and are thought to
contain the highest levels of p34cdc2, the 34-kDa product of
the cdc2 gene [11]. In Arabidopsis thaliana, the highest levels
of cdc2aAt mRNA (now designated CDKA;1 [12]) and pro-
moter activity are found in areas with higher frequencies of,
or potential for, cell division [13,14]. Abundant shoot forma-
tion provoked by R. fascians on A. thaliana has been corre-
lated with a strong induction of CDKA;1 expression [2].
Although CDKA;1 expression can be induced by cytokinins
[14], the unaltered expression levels in plants infected with R.
fascians mutant strain D188-5, which lacks pFiD188, show
that this induction is not mediated by cytokinins originating
from the activity of chromosomally encoded proteins. The
induced CDKA;1 expression must thus be provoked by a
pFiD188-encoded factor [2].
To study aspects of the cell cycle, cell cultures of Nicotiana
tabacum L. cv. Bright Yellow-2 (BY-2) are very suitable: they
grow very fast and homogenously and a high synchrony in
cell division can be induced [15]. Several compounds interfer-
ing with a speci¢c step in the cell cycle can be used to block
the cells at certain points, allowing the investigation of the
e¡ect of external signals on cell cycle progression [15]. The
aim of this study was to determine the e¡ects of R. fascians
on the cell cycle progression of synchronized BY-2 cells. Our
data indicate that induced bacterial cells speci¢cally a¡ect the
cell cycle of tobacco BY-2 cells at the prophase of mitosis.
This e¡ect requires the presence of a fas-dependent molecule.
The importance of this molecule in the interaction between R.
fascians and its host is discussed.
2. Materials and methods
2.1. Bacterial strains and growth conditions
R. fascians strains were grown on YEB at 28‡C [16]. The strains
used were D188 (a highly virulent wild-type isolate), D188-5 (an non-
virulent derivative strain without any plasmid [17]), and fas1 (a non-
virulent mutant strain derived from D188, carrying an insertion in the
ipt gene [3]). R. fascians cells were induced as described [18]. When
appropriate, media were supplemented with chloramphenicol (25 Wg/
ml).
2.2. Amaranthus betacyanin bioassay
This standard cytokinin bioassay was carried out as described [19].
The amount of betacyanin produced was calculated as follows:
[OD5423OD600]sample3[OD5423OD600]dark control.
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2.3. HPLC analysis
The presence of 6-benzyl aminopurine (BAP) in the BY-2 culture
medium was monitored with a HPLC 600LC system (Waters, Mil-
ford, MA, USA) connected to a tunable absorbance detector 486
(Waters) and an chromato-integrator D-2000 (Merck-Hitachi, Darm-
stadt, Germany). The samples were acidi¢ed using tri£uoroacetic acid
(TFA, ¢nal concentration 0.1%) and analyzed on a reverse-phase
column (4U250 mm, Vydac 218TP, C18, 300 Aî , with guard column;
Alltech, Deer¢eld, IL, USA) with water (A) and acetonitrile (B), both
with 0.1% TFA as mobile phases. The gradient was linear from 0 to
50% B in 30 min and 50 to 100% B in 5 min, followed by a 15-min
regeneration in phase A. The £ow rate was 1 ml/min. BAP eluted
around 21.30 min.
2.4. Maintenance, culture synchronization, and infection of tobacco
BY-2 cells
A cytokinin-independent cell line derived from N. tabacum L. cv
BY-2 callus (BY-2) was maintained as described [15] by a weekly 70-
fold dilution in modi¢ed Linsmaier and Skoog medium supplemented
with 0.2 mg/ml of 2,4-dichlorophenoxyacetic acid (2,4-D). Cells were
synchronized as described [15]. In brief, 11^15 ml of a stationary, 7-
day-old culture was grown in 100 ml fresh medium containing 5 mg/l
aphidicolin (Sigma, St. Louis, MO, USA) for 24 h. Then the cells were
washed ¢ve times with 3% (w/v) sucrose and inoculated in 100 ml
fresh medium. Samples of 20 ml were inoculated with 1.5 ml of R.
fascians cells at an OD600 of 2.0 or with the appropriate solution of
the compounds to be tested. When desired, propyzamide was used at
Fig. 1. %MI evolution in aphidicolin-synchronized BY-2 cells. E¡ect of (A) induced R. fascians cells, (B) BAP (1036 M and 1035 M) and (C)
olomoucine (100 and 25 WM). The sample of interest is added immediately after release of the aphidicolin block at time point zero.
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a concentration of 3 WM, equally followed by extensive washing. For
each sample, 750 Wl of the cell culture was allowed to sediment on ice.
After the supernatant was removed, the cells were ¢xed with 1 ml
ethanol/acetic acid (3/1 (v/v)) and kept at 4‡C. To determine the
percentage of mitotic cells in a population (mitotic index, %MI), cells
were washed with 1 ml of water and stained with 2P,6-diamidino-2-
phenylindole (DAPI). Cells displaying mitotic ¢gures were counted
using an Axioscope microscope (Zeiss, Jena, Germany) equipped
with a ¢lterblock 02 (G365 excitation ¢lter, FT 395 beam splitter,
LP 420 barrier ¢lter). For each sample, at least 1000 BY-2 cells
were scored.
3. Results
3.1. R. fascians in£uences the cell cycle of BY-2 cells
By using aphidicolin (Section 2), a synchronized BY-2 cell
culture was obtained that generally showed a maximal %MI
peak between 25 and 35%, 6^7 h after the drug was released
(Fig. 1A). Higher levels of synchrony, comparable to those
described originally [15], were achieved in some experiments
(Fig. 1C). Initial experiments in which synchronized BY-2
cultures were confronted either with non-induced wild-type
D188, mutant D188-5, or fas1 cells of R. fascians did not
reveal any di¡erence in %MI (data not shown). However,
when D188 cells were induced for fas gene expression prior
to infection [18], an e¡ect on the cell cycle behavior of the
tobacco cells was observed. The amount of cells that are in
mitosis at the peak of the %MI curve was not a¡ected (max-
imum di¡erence of 2% between the samples within the experi-
ment, Fig. 1A). 1 h later, with pre-induced D188, consistently
5.6 þ 1.6% more cells were found in mitosis, resulting in a
broadening of the %MI peak, an e¡ect that was not observed
with pre-induced D188-5, fas1 or non-treated control cells.
Cytological analysis did not reveal any di¡erence in cytology
among the treated BY-2 samples (data not shown).
3.2. The peak broadening is not a cytokinin e¡ect
The experiments described above indicate the necessity of
an intact, induced fas locus for the peak broadening e¡ect.
Considering the putative cytokinin-like character of the fas
product [3,4], the e¡ect of BAP on synchronized BY-2 cells
was tested. Addition of BAP to a ¢nal concentration of 1036
M (Fig. 1B) or 1037 M (data not shown) resulted in a 10%
increase of the %MI peak when compared to the control
samples containing D188 or dimethylsulfoxide (DMSO, used
to prepare BAP solutions). At the following time point, how-
ever, the %MI dropped to levels comparable to those of the
DMSO control sample. This result indicates that the R.
fascians-induced peak broadening di¡ers from cytokinin-
mediated changes in BY-2 cell cycle behavior. Higher concen-
trations of BAP (1035 M) also increased the %MI, although
the peak was reached 1 h later (Fig. 1B).
Surprisingly, when a combination of BAP (1036 M) and
induced D188 cells was applied to synchronized BY-2 cul-
tures, no cumulative e¡ect (a higher and broader %MI curve)
was observed. Instead, the %MI curve was similar to that
obtained upon infection with D188, thus a typical broader,
but not a higher curve (Fig. 1B). A possible explanation is
that R. fascians would be able to degrade or inactivate BAP
during the experiment. Therefore, the presence and activity of
BAP was evaluated after overnight incubation of R. fascians
in BY-2 culture medium supplemented with 1036 M BAP.
HPLC analysis revealed that the amount of BAP did not
decrease (Table 1). Furthermore, the activity of BAP mea-
sured by using the Amaranthus caudatus betacyanin assay
[19] also remained una¡ected, indicating that another mecha-
nism underlies the dominant e¡ect of R. fascians over cytoki-
nins on BY-2 cells.
Table 1
E¡ect of R. fascians on the presence and activity of BAP in BY-2 medium after overnight incubation
Sample Amount of BAPa (peak integrated areaU1000) Cytokinin activityb ((OD5423OD600)U1000)
BAP 181 þ 4 17 þ 4
Medium+BAP 190 þ 5 20 þ 3
Medium+BAP+D188 190 þ 11 23 þ 5
Medium+BAP+D188-5 184 þ 5 22 þ 2
aAreas of the BAP peak isolated by HPLC and calculated by the on-line chromato-integrator represent the amount of BAP in each sample;
absorbance is measured at 234 nm.
bMeasured with the Amaranthus betacyanin assay; the BAP concentration used is 1036 M.
Fig. 2. E¡ect of R. fascians on the contribution of each mitotic phase to the total percentage of %MI.
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3.3. R. fascians causes an extended prophase upon infection of
BY-2 cells
An e¡ect of R. fascians on the duration of one or more of
the mitotic phases was considered the basis of the peak broad-
ening. To evaluate this, the number of BY-2 cells in a speci¢c
phase of mitosis were counted. Fig. 2 shows a higher percent-
age of cells in prophase at time point 7 upon D188 treatment
when compared to D188-5, suggesting this increase of propha-
sic cells is the main contribution to the peak broadening ef-
fect. To further investigate this possibility, blocking experi-
ments with double-synchronized cells were designed.
Propyzamide inhibits the polymerization of tubulin [20] and
causes the cells to arrest in prophase, enabling a cell syn-
chrony up to 90% [15]. In one set of experiments, propyza-
mide was added to BY-2 cells immediately after release from
an aphidicolin block, and was washed away after 10 h. Im-
mediately after release from the propyzamide block, the cul-
tures were treated with D188, D188-5, or water (Fig. 3A). In
the double-synchronized cells, D188 had no e¡ect (Fig. 3B).
Previous experiments showed that the peak broadening ef-
fect was induced upon D188 infection of synchronized BY-2
cells 6 h after aphidicolin release, i.e. 1 h prior to the %MI
peak, indicating that little time is required for D188 to exert
its e¡ect (data not shown). The absence of a peak broadening
in double-synchronized BY-2 cells thus excludes a prolonga-
tion of the mitotic phases following prophase and further
suggests that D188 retards the prophase.
In a second set of experiments, bacteria were added to the
BY-2 culture upon release of the aphidicolin block, followed
by application of propyzamide at various time points (Fig.
3A), allowing a fraction of the cells to pass the prophase
before they are blocked. When propyzamide was added 5 or
6 h after aphidicolin release, no major di¡erence in %MI is
found between D188- and D188-5-treated samples (Fig. 3C).
However, when added after 7 h, the amount of cells blocked
in mitosis was higher in the D188-treated sample (9 þ 4%),
implying that BY-2 cells infected with pre-induced D188
cells proceeded through prophase at a slower rate than
Fig. 3. E¡ect of R. fascians on double-synchronized BY-2 cells. A: Schematic representation of the experiment. APC, aphidicolin; PZ, propyza-
mide; Rf, R. fascians cells (or water for the control). The arrows indicate the period in which samples were collected. B: E¡ect of D188,
D188-5, and water added immediately after release from propyzamide (10-h treatment). C: E¡ect of D188 and D188-5 added upon aphidicolin
release followed by addition of propyzamide. The period between addition of the bacteria and propyzamide is indicated in hours.
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D188-5-infected control cells. This also suggests that D188
a¡ects BY-2 cells only in late G2 phase and/or in prophase.
4. Discussion
Cell cycle progression of BY-2 cells depends on the exoge-
nous addition of auxin, but does not require exogenous cyto-
kinin [15]. In aphidicolin-synchronized BY-2 cells, the levels of
speci¢c cytokinins sharply increase at the end of the S phase
and during mitosis [21], suggesting that these hormones play
an important role in cell cycle progression. Similar observa-
tions were made with synchronized suspension cultures of the
N. tabacum L. cv. Xanthi cell strain XD6S, another cytokinin-
autonomous cell line, in which the G2-to-M transition is ac-
companied by a sharp increase of endogenous cytokinin levels
[22]. The increases in cytokinin levels most probably result
from de novo synthesis and not from hydrolysis of O-gluco-
sides [21,23]. Because cytokinins have been shown to in£uence
the plant cell cycle [14,21,23^26], a signal molecule that is
produced by the fas-locus encoded proteins, one of which is
the central enzyme in cytokinin production (IPT; [3]), was
assumed to a¡ect cell division. BY-2 cells are cytokinin auton-
omous and have been selected for their high rate of cell divi-
sion [15]. By using these rapidly dividing cells, a possible
mitogenic e¡ect of (a) R. fascians-derived, putative cytoki-
nin-like signal(s) may remain undetected. To trace a stimulat-
ing activity of R. fascians, or its produced signals, on cell
division, the use of cells that essentially do not divide unless
they are provided with a mitogen is more appropriate.
However, R. fascians was shown to speci¢cally a¡ect the
cell cycle of synchronized tobacco BY-2 cells in a way that
is distinct from the action of cytokinins. Despite the cytokinin
independence of BY-2 cells [15,21,23], addition of BAP (Fig.
1B) or zeatin (data not shown) increases the %MI peak of an
aphidicolin-synchronized culture. This indicates that a signi¢-
cant population of BY-2 cells does not divide in the absence
of this hormone and can be stimulated to enter M-phase.
R. fascians alters the mitotic behavior of synchronized BY-2
cells in a di¡erent way than exogenously applied cytokinins:
the action of (a) fas-dependent product(s) consistently results
in a broader %MI peak (Fig. 1). The data presented suggest
an e¡ect of (a) fas-dependent signal(s) on the prophase, i.e.
the a¡ected BY-2 cells show an extended prophase (Figs. 2
and 3).
Considering the proposed role for the fas locus-encoded
proteins to speci¢cally modify an adenine-based cytokinin
[4], the action of olomoucine, a C2-, N6-, N9-substituted pu-
rine, is of particular interest. Olomoucine has been shown to
slow down the prophase-to-metaphase transition in cleaving
sea urchin embryos, whereas it does not a¡ect the duration of
the metaphase-to-anaphase and anaphase-to-telophase transi-
tions [27]. Such an e¡ect would thus result in a prolonged
prophase, which is quite similar to what is found for R.
fascians D188-infected BY-2 cells. Indeed when the e¡ects
of olomoucine were investigated in our experimental system,
a peak broadening that was reminiscent of the D188-pro-
voked e¡ect was observed at 25 WM (Fig. 1C) or lower con-
centrations (10 and 5 WM; data not shown). At 100 WM (Fig.
1C) or 50 WM (data not shown), which are concentrations
known to stop cell cycle progression in Petunia protoplasts
and A. thaliana cell suspension cultures [28], signi¢cantly
less BY-2 cells entered mitosis, possibly because of the toxic
e¡ects of the drug. Nevertheless, those cells which enter mi-
tosis do show the characteristic peak broadening. Olomoucine
has been found to strongly inhibit only the CDKs CDC2,
CDK2, and CDK5 and, to a minor extent, the ERK1-MAP
kinase [29] by competing for the ATP binding site. Olomou-
cine reduces the in vivo tyrosine dephosphorylation of p34cdc2,
presumably by interruption of the positive feedback loop by
which the CDC2 kinase phosphorylates and hyperactivates
the CDC25 phosphatase [29].
Cytokinins, on the other hand, have been shown to activate
the p34cdc2/cyclinB complex by stimulating dephosphorylation
of the CDK, allowing the cells to enter mitosis [25]. A burst of
cytokinin accumulation in late G2 phase re£ects the essential
role of this hormone in progression of the plant cell cycle
from G2 to M phase [12,21,23]. These data suggest that the
mitosis-promoting e¡ect of exogenously applied BAP on BY-2
cells (Fig. 1B) is also mediated by an activation of the CDK/
cyclinB complex. Interestingly, simultaneous addition of cyto-
kinins and induced D188 cells did not result in a combination
of both e¡ects, but only in a broader %MI peak (Fig. 1B).
Because R. fascians does not degrade or inactivate the added
cytokinin (Table 1), the fas-derived molecule(s) might override
the response of these cells to cytokinin. A possible implication
is that both types of molecules must, at least in part, exert
their e¡ect via the same signal transduction pathway or that a
feedback mechanism exists between two separate pathways.
The exact mode of action of the fas-derived product(s) under-
lying the extension of the prophase remains to be determined.
Acknowledgements: The authors specially thank Danny Vereecke for
critical reading of the manuscript and Martine De Cock for help
preparing it. This work was supported by Grants from Interuniversity
Poles of Attraction Programme (Belgian State, Prime Minister’s O⁄ce
^ Federal O⁄ce for Scienti¢c, Technical and Cultural A¡airs; P4/15)
W.T. is indebted to the Vlaams Instituut voor de Bevordering van het
Wetenschappelijk-Technologisch Onderzoek in de Industrie for a
postdoctoral fellowship.
References
[1] Elia, S., Gossele¤, F., Vantomme, R., Swings, J. and De Ley, J.
(1984) Phytopathol. Z. 110, 89^105.
[2] Vereecke, D., Burssens, S., Simo¤n-Mateo, C., Inze¤, D., Van
Montagu, M., Goethals, K. and Jaziri, M. (2000) Planta 210,
241^251.
[3] Crespi, M., Messens, E., Caplan, A.B., Van Montagu, M. and
Desomer, J. (1992) EMBO J. 11, 795^804.
[4] Crespi, M., Vereecke, D., Temmerman, W., Van Montagu, M.
and Desomer, J. (1994) J. Bacteriol. 176, 2492^2501.
[5] Hunter, T. (1995) Cell 80, 225^236.
[6] Mironov, V., De Veylder, L., Van Montagu, M. and Inze¤, D.
(1999) Plant Cell 11, 509^521.
[7] Lacey, M.S. (1939) Ann. Appl. Biol. 26, 262^278.
[8] Baker, K.F. (1950) Plant Dis. Rep. 34, 121^126.
[9] Roussaux, J. (1965) Rev. Ge¤n. Bot. 72, 21^53.
[10] Lelliott, R.A. (1966) J. Appl. Bacteriol. 29, 114^118.
[11] John, P.C.L., Zhang, K., Dong, C., Diederich, L. and Wightman,
F. (1993) Aust. J. Plant Physiol. 20, 503^526.
[12] Joube's, J., Chevalier, C., Dudits, D., Heberle-Bors, E., Inze¤, D.,
Umeda, M. and Renaudin, J.-P. (2000) Plant Mol. Biol. 43, 607^
620.
[13] Martinez, M.C., Jorgensen, J.-E., Lawton, M.A., Lamb, C.J. and
Doerner, P.W. (1992) Proc. Natl. Acad. Sci. USA 89, 7360^7364.
[14] Hemerly, A.S., Ferreira, P., de Almeida Engler, J., Van Monta-
gu, M., Engler, G. and Inze¤, D. (1993) Plant Cell 5, 1711^1723.
[15] Nagata, T., Nemoto, Y. and Hasezawa, S. (1992) Int. Rev. Cytol.
132, 1^30.
FEBS 24686 5-3-01
W. Temmerman et al./FEBS Letters 492 (2001) 127^132 131
[16] Desomer, J., Dhaese, P. and Van Montagu, M. (1988) J. Bacter-
iol. 170, 2401^2405.
[17] Desomer, J., Crespi, M. and Van Montagu, M. (1991) Mol.
Microbiol. 5, 2115^2124.
[18] Temmerman, W., Vereecke, D., Dreesen, R., Van Montagu, M.,
Holsters, M. and Goethals, K. (2000) J. Bacteriol. 182, 5832^
5840.
[19] Biddington, N.L. and Thomas, T.H. (1973) Planta 111, 183^186.
[20] Akashi, T., Izumi, K., Nagano, E., Enomoto, M., Mizuno, K.
and Shibaoka, H. (1988) Plant Cell Physiol. 29, 1053^1062.
[21] Redig, P., Shaul, O., Inze¤, D., Van Montagu, M. and Van On-
ckelen, H. (1996) FEBS Lett. 391, 175^180.
[22] Nishinari, N. and Syono, K. (1986) Plant Cell Physiol. 27, 147^
153.
[23] Laureys, F., Dewitte, W., Witters, E., Van Montagu, M., Inze¤,
D. and Van Onckelen, H. (1998) FEBS Lett. 426, 29^32.
[24] Soni, R., Carmichael, J.P., Shah, Z.H. and Murray, J.A.H.
(1995) Plant Cell 7, 85^103.
[25] Zhang, K., Letham, D.S. and John, P.C.L. (1996) Planta 200, 2^
12.
[26] Tre¤hin, C., Planchais, S., Glab, N., Perennes, C., Tregear, J. and
Bergounioux, C. (1998) Planta 206, 215^224.
[27] Abraham, R.T., Acquarone, M., Andersen, A., Asensi, A., Belle¤,
R., Berger, F., Bergounioux, C., Brunn, G., Buquet-Fagot, C.,
Fagot, D., Glab, N., Goudeau, H., Goudeau, M., Guerrier, P.,
Houghton, P., Hendriks, H., Kloareg, B., Lippai, M., Marie, D.,
Maro, B., Meijer, L., Mester, J., Mulner-Lorillon, O., Poulet,
S.A., Schierenberg, E., Schutte, B., Vaulot, D. and Verlhac,
M.H. (1995) Biol. Cell 83, 105^120.
[28] Glab, N., Labidi, B., Qin, L.-X., Trehin, C., Bergounioux, C. and
Meijer, L. (1994) FEBS Lett. 353, 207^211.
[29] Vesely¤, J., Havlicek, L., Strnad, M., Blow, J., Donella-Deana, A.,
Pinna, L., Letham, D.S., Kato, J.-y., Detivaud, L., Leclerc, S.
and Meijer, L. (1994) Eur. J. Biochem. 224, 771^786.
FEBS 24686 5-3-01
W. Temmerman et al./FEBS Letters 492 (2001) 127^132132
